Wilmington, Delaware, United States, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - Intense focus by healthcare systems on global control of meningitis has pivoted enormous research on meningococcal vaccines for protection against various age groups and disease strains. The study on the meningococcal vaccines market has observed that conjugate vaccines are widely preferred in mass vaccination programs, thereby driving sizable product sales over the years. The meningococcal vaccine market size was pegged at US$ 4.2 Bn in 2021.
Ongoing clinical programs for meningococcal vaccines by a few globally prominent healthcare and pharmaceutical companies will unlock new revenue streams in global meningococcal vaccines market. A case in point is the vaccine pipeline of Sanofi. Firms are leaning on developing broad-coverage vaccines notably those that can offer protection to children in a bid to capture revenues and gain a competitive edge over peers and rivals.
Initiatives by governments in various countries and efforts by not-for-profit healthcare organizations in increasing the affordability of and access to the vaccines have catalyzed the meningococcal vaccine market growth. As a result, the world has witnessed mass vaccination campaigns in endemic regions particularly Africa over the past few years.
Get Exclusive PDF Sample Copy of Meningococcal Vaccines Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1666
Key Findings of Meningococcal Vaccines Market Study
- Mass Meningococcal Conjugate Vaccine Programs Propelling Sales: Conjugate vaccine type accounted for a major meningococcal vaccine market share in 2021, and will continue to gain widespread adoption in near future. These have been widely preferred due to the good effectiveness, safety, and tolerability. Of note, mass vaccination programs using the vaccine type has demonstrated the ability to induce herd immunity. Thus, commercial approval of conjugate vaccines has enriched the trajectories of the meningococcal vaccines market development.
- Substantial Health Burden of Meningococcal Disease: Developed nations are geared toward supporting long-term research for developing vaccines that are well tolerated in all age groups, a trend found in a granular meningococcal vaccine market analysis. Stridently, these are expected to control meningococcal outbreaks more effectively and quickly, thus helping reducing the global burden of meningococcal disease. According to several studies, such as ones supported by the WHO, mass meningococcal conjugate vaccine campaigns has helped reduced the incidence of the disease since the last decade.
- Firms to Capture Value by Unveiling Safer and Effective Vaccines for Wide Age Range: Stakeholders witness value-grab opportunities in development and commercialization of meningococcal vaccines that are effective for broad age groups, especially for children. Furthermore, massive need for vaccines that can target immune response across all major serogroups will pave the way to new avenues in meningococcal vaccines market.
Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=1666
Meningococcal Vaccines Market: Key Drivers
- Growing awareness of the fact that meningococcal disease has been a leading cause of morbidity and mortality worldwide has fueled R&D in meningococcal vaccines. High prevalence of meningitis and glaring burden of invasive meningococcal disease are driving the uptake of vaccines in mass immunization programs, especially in endemic regions.
- Steadily growing number of product approval and market authorization of vaccines that protect against wide range of common pathogenic meningococcal serogroups is a key driver of meningococcal vaccines market.
Meningococcal Vaccines Market: Regional Dynamics
- North America held a major share of the global meningococcal vaccines market in 2021, and is anticipated to remain attractive until the end of the forecast period. Rise in R&D on various meningococcal strains, reinforced by government support, and rising awareness of the incidence of the disease in the U.S. in recent years are key factors that engenders revenue potential.
- Asia Pacific is a potentially lucrative market, and the opportunities in the regional market are projected to expand at promising pace during the forecast period. Rising patient pool and increasing awareness of the mortality and morbidity of invasive meningococcal disease are fueling the prospects.
Meningococcal Vaccines Market: Key Players
Some of the key players in the meningococcal vaccines market are Biomed Pvt. Ltd., Baxter International, Serum Institute of India Ltd., Pfizer Inc., GSK plc, Novartis International, and Sanofi SA.
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1666
Meningococcal Vaccines Market Segmentation
- Type
- Polysaccharide
- Menomune
- Mencevax
- NmVac4
- Others
- Conjugate Vaccines
- Menactra
- Menveo
- NeisVac-C
- Nimenrix
- Meningitec
- Menjugate
- MenAfriVac
- NmVac4-DT
- Combination Vaccines
- MenHibrix
- Menitorix
- Men B Vaccines
- Bexsero
- Trumenba
- Polysaccharide
- End-user
- Retail Pharmacies
- Hospital Pharmacies
- Others (online pharmacies, drug stores)
Regions
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Countries
- U.S.
- Canada
- Germany
- U.K.
- France
- Spain
- Italy
- Russia & CIS
- Japan
- China
- India
- ASEAN
- Brazil
- Mexico
- GCC
- South Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Anti-aging Market: The global anti-aging market for anti-wrinkle products was valued at US$ 8,400.0 Mn in 2018 and is projected to expand at a CAGR of 6.0% from 2019 to 2027.
Red Biotechnology Market: The global red biotechnology market is anticipated to reach more than US$ 609.6 Bn by the end of 2031.
Equine Supplement Products Market: The global equine supplement products market is anticipated to reach US$ 111 Mn by the end of 2031. The global market is projected to grow at a CAGR of 3.7% from 2022 to 2031
Skincare Serum Market: The global skincare serum market is anticipated to reach more than US$ 6.28 Bn by the end of 2031 with a CAGR of 7.4% from 2022 to 2031.
Epilepsy Therapeutics Market: The global epilepsy therapeutics market is anticipated to reach more than US$ 14.9 Bn by the end of 2031.
Smart Insulin Pens Market: The global smart insulin pens market size is prognosticated to expand at notable pace and reach a value of US$ 90.1 Mn by the end of 2031
Vitamin D Testing Market: The global vitamin D testing market is anticipated to reach more than US$ 1.06 Bn by the end of 2031 with a CAGR of 5.8 % from 2022 to 2031
Laboratory Gas Generators Market: The global laboratory gas generators market is anticipated to reach more than US$ 1.27 Bn by the end of 2031 with a CAGR of 11.0% from 2022 to 2031
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
